These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child. Zheng Y; Nong L; Liang L; Wang W; Li T Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385 [TBL] [Abstract][Full Text] [Related]
10. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282 [TBL] [Abstract][Full Text] [Related]
12. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia. Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941 [TBL] [Abstract][Full Text] [Related]
13. Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation. Chen TY; Chen JS; Huang WT; Su WC; Tsao CJ Bone Marrow Transplant; 2003 Jul; 32(1):111-4. PubMed ID: 12815487 [TBL] [Abstract][Full Text] [Related]
14. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val. Sperr WR; Walchshofer S; Horny HP; Födinger M; Simonitsch I; Fritsche-Polanz R; Schwarzinger I; Tschachler E; Sillaber C; Hagen W; Geissler K; Chott A; Lechner K; Valent P Br J Haematol; 1998 Dec; 103(3):740-9. PubMed ID: 9858225 [TBL] [Abstract][Full Text] [Related]
15. The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review. Leguit R; Hebeda K; Kremer M; van der Walt J; Gianelli U; Tzankov A; Orazi A Pathobiology; 2020; 87(1):2-19. PubMed ID: 31802761 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy. Samorapoompichit P; Schernthaner GH; Worda C; Wimazal F; Krauth MT; Sperr WR; Valent P Histopathology; 2006 Feb; 48(3):247-57. PubMed ID: 16430471 [TBL] [Abstract][Full Text] [Related]
17. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge. Arredondo AR; Gotlib J; Shier L; Medeiros B; Wong K; Cherry A; Corless C; Arber DA; Valent P; George TI Am J Hematol; 2010 Aug; 85(8):600-6. PubMed ID: 20658589 [No Abstract] [Full Text] [Related]
18. [Mastocytosis, classification, biological diagnosis and therapy]. Arock M Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. Valent P; Sperr WR; Schwartz LB; Horny HP J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337 [TBL] [Abstract][Full Text] [Related]
20. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management. Pardanani A Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]